Panbela Therapeutics Inc. buy Roth Mkm
Start price
05.02.24
/
50%
€90.36
Target price
05.02.25
€23.26
Performance (%)
-
End price
06.02.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Panbela Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 0.224% | 2.457% | 21.634% |
| iShares Nasdaq 100 | 0.371% | -0.320% | 5.422% |
| iShares Nikkei 225® | 0.972% | -0.829% | 15.333% |
| iShares S&P 500 | 0.417% | -0.157% | 3.125% |
Comments by Roth_Mkm for this prediction
In the thread Panbela Therapeutics Inc. diskutieren
Panbela Therapeutics, Inc. (NASDAQ: PBLA) had its price target lowered by analysts at Roth Mkm from $500.00 to $25.00. They now have a "buy" rating on the stock.
Ratings data for PBLA provided by MarketBeat
In the thread Trading Panbela Therapeutics Inc.
Die von Roth_Mkm gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Roth_Mkm for Panbela Therapeutics Inc.
Panbela Therapeutics Inc.
Start price
Target price
Perf. (%)
€90.36
27.03.24
27.03.24
€23.10
27.03.25
27.03.25
-
28.03.25
28.03.25
Panbela Therapeutics Inc.
Start price
Target price
Perf. (%)
€90.36
18.12.23
18.12.23
€22.90
18.12.24
18.12.24
-
19.12.24
19.12.24

